DHR Health and Cipherome to Pioneer Personalized Medicine Project in Patients Undergoing Percutaneous Coronary Interventions dlvr.it/RthH8T

Cipherome Leadership Visits DHR Health to Discuss the Value of Genetic-Based Study in Patients Undergoing Percutaneous Coronary Intervention megadoctornews.com/cipherome-lead…

Congratulations to our Scientific Advisory Board Member Dr. Marylyn D. Ritchie for being elected as a new member of the NAM! This honor is for those with extraordinary contributions in biomedical science, health, and medicine. Dr. Marylyn D. Ritchie, PhD National Academy of Medicine #personalizedmedicine

🧬Happy Lunar New Year from Cipherome🧬 Wishing everyone a wonderful Year of the Tiger!

Today is US National ADR Awareness Day! Cipherome we work to reduce patient risk by helping physicians provide the Right Drug. The Right Dose. Right Now. #Cipherome

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other possible drug-related problem World Health Organization (WHO) #Cipherome

An adverse drug event is an injury resulting from medical intervention related to a drug. Deaths due to preventable adverse drug events exceed the deaths attributable to motor vehicle accidents, breast cancer or AIDS. CDC National Academy of Medicine #Cipherome

In one year, the U.S. spends an estimated $528 billion on non-optimized medications, exceeding the cost of the drugs themselves—and the cost of all major diseases. Annals of Pharmacotherapy Journal #Cipherome

The rate of adverse drug events are twice as high for women, according to the FDA Adverse Event Reporting System. U.S. FDA #Cipherome

New prescription drugs have a 1 in 5 chance of causing serious reactions after they have been approved. Edmond & Lily Safra Center for Ethics #Cipherome

Studies show that up to 99 percent of the population has at least one genetic variation that may influence their response to medications. Mayo Clinic #Cipherome

Given the U.S. population’s large and ever-increasing magnitude of medication exposure, the potential for harm from adverse drug events constitutes a critical patient safety and public health challenge. HHS #Cipherome

#Cipherome is excited to attend and speak at #PMWC22! If you are attending Precision Medicine World Conference, come and say hello at booth C1018 to learn more about our Xentinel® Lighthouse product Precision Medicine World Conference